Optimer Pharmaceuticals (OPTR) surges 18.1% following a report that the antibiotics maker has...

|About: Optimer Pharmaceuticals, ... (OPTR)|By:, SA News Editor

Optimer Pharmaceuticals (OPTR) surges 18.1% following a report that the antibiotics maker has attracted takeover interest from GlaxoSmithKline (GSK), AstraZeneca (AZN), Cubist Pharmaceuticals (CBST) and Japan's Astellas. Optimer hopes to fetch up to $1B in an auction, well above its market cap of $660M. The company has one drug on the market, Dificid, which is used to treat intestinal infections in hospitalized patients.